Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts hepatocellular carcinoma incidence and recurrence in nucleos(t)ide analogue therapy for chronic hepatitis B

2017 ◽  
Vol 53 (6) ◽  
pp. 740-751 ◽  
Author(s):  
Kazunori Kawaguchi ◽  
Masao Honda ◽  
Hajime Ohta ◽  
Takeshi Terashima ◽  
Tetsuro Shimakami ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Binding Protein ◽  
Wisteria Floribunda

scholarly journals Mac-2 Binding Protein Glycosylation Isomer as a Hepatocellular Carcinoma Marker in Patients With Chronic Hepatitis B or C Infection

2019 ◽  
Vol 3 (4) ◽  
pp. 493-503 ◽  
Author(s):  
Tomi Jun ◽  
Yao-Chun Hsu ◽  
Shintaro Ogawa ◽  
Yen-Tsung Huang ◽  
Ming-Lun Yeh ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Binding Protein ◽  
Protein Glycosylation

Serum Mac‐2‐binding protein glycosylation isomer and risk of hepatocellular carcinoma in entecavir‐treated chronic hepatitis B patients

2019 ◽  
Vol 34 (10) ◽  
pp. 1817-1823 ◽  
Author(s):  
Lung‐Yi Mak ◽  
Michael Ko ◽  
Elvis To ◽  
Danny Ka‐Ho Wong ◽  
Justin Hei‐Chun Ma ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Binding Protein ◽  
Protein Glycosylation

Serum Mac-2-Binding Protein Glycosylation Isomer at Virological Remission Predicts Hepatocellular Carcinoma and Death in Chronic Hepatitis B-Related Cirrhosis

2019 ◽  
Author(s):  
Tung-Hung Su ◽  
Cheng-Yuan Peng ◽  
Tai-Chung Tseng ◽  
Hung-Chih Yang ◽  
Chun-Jen Liu ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Antiviral Therapy ◽  
Chronic Hepatitis B ◽  
Binding Protein ◽  
Cox Proportional Hazards ◽  
Protein Glycosylation ◽  
Derivation Cohort ◽  
The Mean

Abstract Background To investigate serum Mac-2-binding protein glycosylation isomer (M2BPGi) levels in predicting hepatocellular carcinoma (HCC) and mortality at virological remission (VR, HBV DNA <20 IU/mL) following antiviral therapy in chronic hepatitis B (CHB) patients with cirrhosis. Methods This retrospective cohort study included patients with CHB-related Child-Pugh A cirrhosis undergoing long-term antiviral therapy. Serum M2BPGi levels were quantified and multivariable Cox proportional hazards regression models were used to identify risk predictors for HCC and death. Results A total of 126 and 145 patients were included in the derivation and validation cohorts, respectively. The mean age was 56, and the mean M2BPGi level was 1.86 cut-off index (COI) in the derivation cohort. After adjustment for confounders, a higher M2BPGi level at VR significantly predicted HCC (hazard ratio [HR]: 1.58, 95% confidence interval [CI]: 1.19-2.10, P=0.002) and death (HR: 2.17, 95% CI: 1.02-4.62, P=0.044). The M2BPGi ³3 COI significantly increased the risk of HCC and death in the derivation and validation cohorts. Serial M2BPGi levels declined significantly (P=0.0001) in non-HCC patients only, and remained significantly lower than those who developed HCC afterwards (P=0.039). Conclusions Serum M2BPGi levels at antiviral therapy-induced VR predict HCC development and death in patients with CHB-related Child-Pugh A cirrhosis.

scholarly journals Serum Wisteria floribunda agglutinin‐positive Mac‐2‐binding protein for patients with chronic hepatitis B and C: a comparative study

2016 ◽  
Vol 23 (12) ◽  
pp. 977-984 ◽  
Author(s):  
H. Nishikawa ◽  
H. Enomoto ◽  
Y. Iwata ◽  
K. Kishino ◽  
Y. Shimono ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Comparative Study ◽  
Chronic Hepatitis B ◽  
Binding Protein ◽  
Wisteria Floribunda
Sign in / Sign up

Export Citation Format

Share Document